Fitch places Athenahealth on rating watch negative amid $17B acquisition

Fitch Ratings placed Athenahealth on rating watch negative following the Watertown, Mass.-based EHR vendor’s recent agreement to be acquired by private equity firms Hellman & Friedman and Bain Capital.

Advertisement

The credit rating agency said it expects a material increase in debt to fund the $17 billion transaction and would look to resolve the rating watch negative after the deal’s financing terms close, according to a Nov. 29 news release. 

Athenahealth on Nov. 22 announced its agreement to be jointly acquired by Hellman & Friedman and Bain Capital. Private equity firms Veritas Capital and Elliott Investment Management bought Athenahealth in February 2019 for $5.7 billion. 

While the financing terms of Athenahealth’s current acquisition agreement were not disclosed, Fitch said it estimates that a typical leveraged buyout in this situation would result in an increase of borrowed capital.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in EHRs / Interoperability

Advertisement

Comments are closed.